country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Piribedil, a dopamine agonist, in Parkinson's disease

Clin Pharmacol Ther. 1974 Dec;16(6):1077-82. doi: 10.1002/cpt19741661077.

R D Sweet , C G Wasterlain , F H McDowell

PMID: 4611465 DOI: 10.1002/cpt19741661077

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-12707

Piribedil

99.92%, Dopamine D2/D3 Agonist

target: Dopamine Receptor; Adrenergic Receptor; Histone Methyltransferase

Research Areas: Neurological Disease; Endocrinology; Cancer
HY-12707A

Piribedil dihydrochloride

Dopamine D2/D3 Agonist

target: Adrenergic Receptor; Dopamine Receptor; Histone Methyltransferase

Research Areas: Neurological Disease; Endocrinology; Cancer
HY-12707C

Piribedil hydrochloride

Dopamine D2/D3 Agonist

target: Dopamine Receptor; Adrenergic Receptor; Histone Methyltransferase

Research Areas: Neurological Disease; Endocrinology; Cancer
HY-12707R

Piribedil (Standard)

Dopamine D2/D3 Agonist

target: Reference Standards; Dopamine Receptor; Adrenergic Receptor; Histone Methyltransferase

Research Areas: Neurological Disease; Endocrinology; Cancer
HY-12707B

Piribedil maleate

Dopamine D2/D3 Agonist

target: Dopamine Receptor; Adrenergic Receptor; Histone Methyltransferase

Research Areas: Neurological Disease; Endocrinology; Cancer
HY-133728

Piribedil N-oxide

Drug Metabolite

target: Drug Metabolite; Dopamine Receptor

Research Areas: Neurological Disease